Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia
- 1 September 1988
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 12 (3-4) , 179-187
- https://doi.org/10.1016/s0149-7634(88)80039-3
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Neuroleptic malignant syndrome: review and analysis of 115 casesBiological Psychiatry, 1987
- Extrapyramidal reactions with metoclopramide.BMJ, 1985
- The Neuroleptic Malignant Syndrome: Do we Know Enough?Jefferson Journal of Psychiatry, 1985
- Brief ReportClinical Neuropharmacology, 1984
- Neuroleptic-Induced Dyskinesias in ChildrenClinical Neuropharmacology, 1983
- Neuroleptic Malignant syndrome caused by dopamine‐depleting drugs in a patient with Huntington diseaseNeurology, 1981
- The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassayBrain Research, 1981
- Stimulation of Dopamine Synthesis in Caudate Nucleus by Intrastriatal Enkephalins and Antagonism by NaloxoneScience, 1978
- REDUCED GLUTAMIC-ACID- DECARBOXYLASE ACTIVITY OF POST-MORTEM BRAIN IN HUNTINGTON'S CHOREAThe Lancet, 1973
- TETRABENACINE TREATMENT IN PERSISTING DYSKINESIA CAUSED BY PSYCHOPHARMACAAmerican Journal of Psychiatry, 1961